BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 12807238)

  • 1. Preoperative serum vascular endothelial growth factor (VEGF) in ovarian masses.
    Tanir HM; Ozalp S; Yalcin OT; Colak O; Akcay A; Senses T
    Eur J Gynaecol Oncol; 2003; 24(3-4):271-4. PubMed ID: 12807238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.
    Cooper BC; Ritchie JM; Broghammer CL; Coffin J; Sorosky JI; Buller RE; Hendrix MJ; Sood AK
    Clin Cancer Res; 2002 Oct; 8(10):3193-7. PubMed ID: 12374688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CA 125 and vascular endothelial growth factor in the differential diagnosis of epithelial ovarian tumors.
    Candido Dos Reis F; Moreira de Andrade J; Bighetti S
    Gynecol Obstet Invest; 2002; 54(3):132-6. PubMed ID: 12571433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with suspected ovarian cancer.
    Obermair A; Tempfer C; Hefler L; Preyer O; Kaider A; Zeillinger R; Leodolter S; Kainz C
    Br J Cancer; 1998 Jun; 77(11):1870-4. PubMed ID: 9667661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor in ovarian cyst fluid.
    Boss EA; Massuger LF; Thomas CM; Geurts-Moespot A; Boonstra H; Sweep CG
    Cancer; 2001 Jan; 91(2):371-7. PubMed ID: 11180084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
    Czekierdowski A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of serum vascular endothelial growth levels between patients with and without ovarian malignancies.
    Dehaven K; Taylor DD; Gercel-Taylor C
    Int J Gynecol Cancer; 2002; 12(6):715-9. PubMed ID: 12445248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor (VEGF) improves the sensitivity of CA125 for differentiation of epithelial ovarian cancers from ovarian cysts.
    Robati M; Ghaderi A; Mehraban M; Shafizad A; Nasrolahi H; Mohammadianpanah M
    Arch Gynecol Obstet; 2013 Oct; 288(4):859-65. PubMed ID: 23564055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adding cancer antigen 125 screening to gray scale sonography for predicting specific diagnosis of benign adnexal masses in premenopausal women: is it worthwhile?
    Alcázar JL; Guerriero S; Mínguez JÁ; Ajossa S; Paoletti AM; Ruiz-Zambrana A; Jurado M
    J Ultrasound Med; 2011 Oct; 30(10):1381-6. PubMed ID: 21968488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum preoperative vascular endothelial growth factor (VEGF) in epithelial ovarian cancer: relationship with prognostic variables and clinical outcome.
    Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Ciampi B; Prontera C; Genazzani AR
    Anticancer Res; 1999; 19(2B):1401-5. PubMed ID: 10365113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor in adnexal masses.
    Demirkiran F; Kumbak B; Bese T; Arvas M; Benian A; Aydin S; Uzun H; Sanioglu C; Aydinli K; Kösebay D
    Int J Gynaecol Obstet; 2003 Oct; 83(1):53-8. PubMed ID: 14511872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
    Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
    Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels.
    Yamamoto S; Konishi I; Mandai M; Kuroda H; Komatsu T; Nanbu K; Sakahara H; Mori T
    Br J Cancer; 1997; 76(9):1221-7. PubMed ID: 9365173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer.
    Lin SY; Wang YY; Sheu WH
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):513-8. PubMed ID: 12641636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy.
    Bozkurt M; Yumru AE; Aral I
    Eur J Gynaecol Oncol; 2013; 34(6):540-4. PubMed ID: 24601047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
    Peng XP; Li JD; Li MD; Ye XM; Yan WC
    Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HE4, CA125, the Risk of Malignancy Algorithm and the Risk of Malignancy Index and complex pelvic masses - a prospective comparison in the pre-operative evaluation of pelvic masses in an Australian population.
    Richards A; Herbst U; Manalang J; Pather S; Saidi S; Tejada-Berges T; Tan K; Williams P; Carter J
    Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):493-7. PubMed ID: 26172511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we preoperatively risk stratify ovarian masses for malignancy?
    Oltmann SC; Garcia N; Barber R; Huang R; Hicks B; Fischer A
    J Pediatr Surg; 2010 Jan; 45(1):130-4. PubMed ID: 20105592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of ultrasound features and the Risk of Ovarian Malignancy Algorithm score for different histopathological subtypes of benign adnexal masses.
    Ionescu CA; Matei A; Navolan D; Dimitriu M; Bohâltea R; Neacsu A; Ilinca C; Ples L
    Medicine (Baltimore); 2018 Aug; 97(31):e11762. PubMed ID: 30075600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.